Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non–small-cell lung cancer

TSK Mok, YL Wu, CJ Yu, C Zhou, YM Chen… - Journal of Clinical …, 2009 - ascopubs.org
Purpose This study investigated whether sequential administration of erlotinib and
chemotherapy improves clinical outcomes versus chemotherapy alone in unselected …
被引用次数：280 相关文章

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

TSK Mok, YL Wu, CJ Yu, C Zhou, YM Chen… - Journal of Clinical …, 2009 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> This study investigated whether
sequential administration of erlotinib and chemotherapy improves clinical outcomes versus …

[引用][C] Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

TSK MOK, YL WU, M CHUA-TAN… - Journal of clinical …, 2009 - pascal-francis.inist.fr
Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As
First-Line Treatment for Advanced Non-Small-Cell Lung Cancer CNRS Inist Pascal-Francis …
[PDF] researchgate.net

[PDF][PDF] Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

TSK Mok, YL Wu, CJ Yu, C Zhou, YM Chen, L Zhang… - Oncology, 2008 - researchgate.net
Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy
As First-Line Treatment for Advanced Non Page 1 Randomized, Placebo-Controlled, Phase …

Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer.

TS Mok, YL Wu, CJ Yu, C Zhou, YM Chen… - Journal of Clinical …, 2009 - europepmc.org
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as
first-line treatment for advanced non-small-cell lung cancer. - Abstract - Europe PMC Sign in …

Randomized, Placebo-Controlled, Phase Ii Study of Sequential Erlotinib and Chemotherapy as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

CJEN YU, YUHMIN CHEN - JOURNAL OF CLINICAL …, 2009 - ntur.lib.ntu.edu.tw
Purpose This study investigated whether sequential administration of erlotinib and
chemotherapy improves clinical outcomes versus chemotherapy alone in unselected …

Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer

TSK Mok, YL Wu, CJ Yu, C Zhou… - Journal of clinical …, 2009 - pubmed.ncbi.nlm.nih.gov
Purpose This study investigated whether sequential administration of erlotinib and
chemotherapy improves clinical outcomes versus chemotherapy alone in unselected …

Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer

TSK Mok, YL Wu, CJ Yu, C Zhou, YM Chen… - Journal of Clinical …, 2009 - scholar.ui.ac.id
Purpose: This study investigated whether sequential administration of erlotinib and
chemotherapy improves clinical outcomes versus chemotherapy alone in unselected …
[PDF] academia.edu

[PDF][PDF] Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

TSK Mok, YL Wu, CJ Yu, C Zhou, YM Chen, L Zhang… - Oncology, 2008 - academia.edu
Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy
As First-Line Treatment for Advanced Non Page 1 Randomized, Placebo-Controlled, Phase …

[引用][C] Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

TSK MOK, YL WU, CJ YU… - Journal of …, 2009 - American Society of Clinical …